The effect of SC administration of GAD-alum observed in the few patients included in this study is in line with the results from previous GAD-alum trials, where we observed only a transient increase of IgG3 and IgG4 and a reduction of IgG1 after SC administration of 2 doses of the same concentration [26, 28]. Here, GAD1 is linked to generalized anxiety disorder.